Elizabeth A. Grammer, Director of Sagimet Biosciences SGMT, has filed 0 purchases and 17 sales on the open market. Over the past 12 months that comes to a net sale of $33.2K. The latest trade was on 06/12.

EG

EG

Elizabeth A. Grammer

Director

Company

Sagimet Biosciences SGMT

First filing

23/01/06

Trades

32 trades

Buys / sales

0 / 17

12-month net buying

−$33.2K

Last trade

06/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
ArdelyxARDX	Open-market sale	25/11/21	25/11/25	5,995 sh	$5.54	$33,212.3	−2.0%
ArdelyxARDX	Open-market sale	25/08/21	25/08/25	5,841 sh	$5.93	$34,637.13	−1.9%
ArdelyxARDX	Open-market sale	25/05/20	25/05/22	5,992 sh	$4.08	$24,447.36	−1.9%
ArdelyxARDX	Open-market sale	25/02/20	25/02/21	4,291 sh	$5.62	$24,115.42	−2.3%
ArdelyxARDX	Open-market sale	24/11/20	24/11/22	7,046 sh	$4.79	$33,750.34	−3.7%
ArdelyxARDX	Open-market sale	24/08/20	24/08/22	7,089 sh	$5.86	$41,541.54	−3.6%
ArdelyxARDX	Open-market sale	24/05/21	24/05/23	6,927 sh	$7.81	$54,099.87	−3.4%
ArdelyxARDX	Open-market sale	24/05/06	24/05/09	284,170 sh2 trades	$8.88avg.	$2,522,787.27	−58.2%
ArdelyxARDX	Open-market sale10b5-1 plan	24/05/03	24/05/07	45,000 sh	$9.00	$405,000	−14.4%
ArdelyxARDX	Open-market sale10b5-1 plan	24/03/20	24/03/22	86,000 sh	$7.73	$664,780	−21.6%
ArdelyxARDX	Open-market sale	24/02/20	24/02/22	4,432 sh	$8.75	$38,780	−1.1%
ArdelyxARDX	Open-market sale10b5-1 plan	23/12/11	23/12/13	50,000 sh	$5.08	$254,000	−15.4%
ArdelyxARDX	Open-market sale	23/11/20	23/11/22	2,384 sh	$4.36	$10,394.24	−0.7%
ArdelyxARDX	Open-market sale	23/08/21	23/08/23	2,392 sh	$3.55	$8,491.6	−0.7%
ArdelyxARDX	Open-market sale	23/05/23	23/05/25	2,384 sh	$3.65	$8,701.6	−0.7%
ArdelyxARDX	Open-market sale	23/02/21	23/02/24	2,914 sh	$3.00	$8,742	−0.9%